Biogen Idec Upgraded On Tysabri Outlook
Forbes - NY,USA
... Stearns upgraded shares of Biogen Idec to "peer perform" from "underperform" on Monday and said the prospects for multiple sclerosis drug Tysabri look brighter ...

Options Update: Elan Wrestles With 15
Schaeffers Research - Cincinnati,Ohio,USA
... However, the company did note that it is encouraged by the initial results from the re-launch of its Tysabri. A quick refresher ...

---

NeuroVax™

The Immune Response Corporation to Present at the Rodman & Renshaw ...
Business Wire (press release) - San Francisco,CA,USA
... CRO) with extensive experience in conducting multiple sclerosis (MS) trials, to oversee a 200-patient Phase IIb trial of NeuroVax™, an investigational T-cell ...

---